Plain-English translation of NCT06642363 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing whether astaxanthin, a natural antioxidant supplement derived from seafood and algae, can help improve symptoms and heart health in women with polycystic ovary syndrome (PCOS). The medication has shown promise in early research for reducing inflammation and improving cholesterol levels. Researchers want to see if this treatment can help with both the reproductive symptoms and metabolic problems that come with PCOS.
PCOS affects millions of women and can cause irregular periods, weight gain, heart problems, and difficulty getting pregnant. While lifestyle changes help, they're not always enough on their own, and current medications have limitations. This trial explores whether this medication might offer an additional natural option to help manage the condition's symptoms and protect heart health.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to take either the astaxanthin supplement or a placebo (dummy pill) that looks identical. You'll take your assigned treatment daily while researchers track how it affects your PCOS symptoms, cholesterol levels, and overall health markers through blood tests and clinical assessments. The study involves about 44 women total, and you'll need to commit to taking at least 80% of your doses and maintaining your normal lifestyle throughout the trial.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Iran